Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Steve R. Zeldenrust"'
Autor:
Eli Muchtar, Susanne R. Hayman, David Dingli, Morie A. Gertz, Amie Fonder, Shaji Kumar, Steve R. Zeldenrust, Stephen J. Russell, Angela Dispenzieri, Francis K. Buadi, Rahma Warsame, Nelson Leung, Miriam Hobbs, Prashant Kapoor, Taxiarchis Kourelis, Martha Q. Lacy, Ronald S. Go, S. Vincent Rajkumar, Wilson I. Gonsalves, Yi L. Hwa, Robert A. Kyle
Publikováno v:
Leukemia. 33:1268-1272
It is well known that staging of patients with AL amyloidosis at diagnosis predicts for survival, but there is a paucity of literature delineating the prognostic value of these systems at relapse. We evaluated the prognostic value of AL staging among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3255049a9e37496853724454a53c658
https://doi.org/10.1038/s41375-019-0400-5
https://doi.org/10.1038/s41375-019-0400-5
Autor:
Kyle W. Klarich, Steve R. Zeldenrust, Richard C. Daly, Brooks S. Edwards, Morie A. Gertz, Martha Grogan, Dipti Banerjee, Julie K. Heimbach, Paul L. Swiecicki, John J. Poterucha, Angela Dispenzieri, Lindsey E. Roeker
Publikováno v:
Progress in Transplantation. 27:246-250
Background: Familial transthyretin amyloidosis is a disease caused by misfolded transthyretin aggregates that can impair multiple organ systems. Liver transplantation is the first-line treatment for familial transthyretin amyloidosis. Research Questi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b85ae4e81f63f2a8ee0341011a1572
https://doi.org/10.1177/1526924817715463
https://doi.org/10.1177/1526924817715463
Autor:
Yi L. Hwa, Shaji Kumar, Morie A. Gertz, Francis K. Buadi, Taxiarchis Kourelis, Ronald S. Go, Wilson I. Gonsalves, David Dingli, Prashant Kapoor, Angela Dispenzieri, Susanne R. Hayman, Steve R. Zeldenrust, Miriam Hobbs, Nelson Leung, Amie Fonder, Martha Q. Lacy, Stephen J. Russell, Rahma Warsame, S. Vincent Rajkumar
Publikováno v:
Blood. 130(13)
Among patients with immunoglobulin light chain (AL) amyloidosis, there is little consensus on when reinstitution of chemotherapy should occur. We conducted a retrospective study to evaluate the patterns of relapse or progression (R/P) and the timing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807cf8be166c4389896e3d8c8a2979d1
https://pubmed.ncbi.nlm.nih.gov/28807981
https://pubmed.ncbi.nlm.nih.gov/28807981
Autor:
Nelson Leung, Shaji Kumar, Steve R. Zeldenrust, Jerry A. Katzmann, Suzanne R. Hayman, Marina Ramirez-Alvarado, Morie A. Gertz, Colin L. Colby, S. Vincent Rajkumar, Martha Q. Lacy, Raynell J. Clark, Francis K. Buadi, Dirk R. Larson, Angela Dispenzieri, Robert A. Kyle
Publikováno v:
Blood. 116:5126-5129
Immunoglobulin free light chains (FLCs) are the precursors of amyloid fibrils in primary amyloidosis (AL). We studied the relationship between FLC levels and clinical features in 730 patients with newly diagnosed AL. The plasma cell clone was λ in 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cc8a1308895262a321bc5f75445aebb
https://doi.org/10.1182/blood-2010-06-290668
https://doi.org/10.1182/blood-2010-06-290668
Autor:
Vincent Rajkumar, Morie A. Gertz, Martha Grogan, John A. Lust, Giampaolo Merlini, Mathew S. Maurer, Shaji Kumar, Yi Hwa, Robert A. Kyle, Francis K. Baudi, Angela Dispenzieri, Paolo Milani, Martha Q. Lacy, Yi Lin, Ronald S. Go, Nelson Leung, Prashant Kapoor, David Dingli, Suzanne R. Hayman, Kyle W. Klarich, Steve R. Zeldenrust
Publikováno v:
Journal of the American College of Cardiology. 67:1601
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32e0cf558cf72c07dbca997bccd6ad4d
https://doi.org/10.1016/s0735-1097(16)31602-3
https://doi.org/10.1016/s0735-1097(16)31602-3
Autor:
Morie A. Gertz, Nelson Leung, Steve R. Zeldenrust, S. Vincent Rajkumar, Shaji Kumar, Philip R. Greipp, Colin L. Colby, David Dingli, Martha Q. Lacy, Stephen J. Russell, Suzanne R. Hayman, Kristina Laumann, Angela Dispenzieri, Robert A. Kyle, Francis K. Buadi, John A. Lust
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(9)
Purpose Cardiac involvement predicts poor prognosis in light chain (AL) amyloidosis, and the current prognostic classification is based on cardiac biomarkers troponin-T (cTnT) and N-terminal pro–B-type natriuretic peptide (NT-ProBNP). However, long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74bac1f7ae56ea80928abf710eaf5f4b
https://pubmed.ncbi.nlm.nih.gov/22331953
https://pubmed.ncbi.nlm.nih.gov/22331953
Autor:
Robert A. Kyle, Shaji Kumar, Morie A. Gertz, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, S. Vincent Rajkumar, Nelson Leung, Suzanne R. Hayman, Steve R. Zeldenrust
Publikováno v:
Mayo Clinic proceedings. 83(3)
To determine the prognostic value of serum uric acid (UA) in patients with primary systemic (light chain) amyloidosis (AL).A cohort of 1977 patients with newly diagnosed AL seen at our institution between April 1, 1960, and August 1, 2006, and 293 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9fe79e8aae817aed4d8d2825bd11be
https://pubmed.ncbi.nlm.nih.gov/18315995
https://pubmed.ncbi.nlm.nih.gov/18315995
Autor:
Marina Ramirez-Alvarado, Steve R. Zeldenrust, Angela Dispenzieri, Nelson Leung, Batia Kaplan, Gloria Gallo, Avi Livneh
Publikováno v:
Clinical Chemical Laboratory Medicine. 46
Background The presence of monoclonal immunoglobulin free light chains (FLC) in the serum is commonly associated with the gammopathies, including multiple myeloma, systemic light chain amyloidosis and non-amyloid light chain deposition disease. Altho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f07aee28bc1b8711dd545b449b28f7
https://doi.org/10.1515/cclm.2008.068
https://doi.org/10.1515/cclm.2008.068
Autor:
Angela Dispenzieri, Alan H. Bryce, Rafael Fonseca, Rhett P. Ketterling, Shaji Kumar, Suzanne R. Hayman, Martha Q. Lacy, John A. Lust, David Dingli, P R Greipp, Steve R. Zeldenrust, Robert A. Kyle, Vincent Rajkumar, Morie A. Gertz, Francis K. Buadi, Stephen J. Russell
Publikováno v:
Blood. 110:2477-2477
Background: Primary systemic amyloidosis is an uncommon plasma cell dyscrasia characterized by organ deposition of immunoglobulin light or heavy chain fragments. It is related to the other plasma cell dyscrasias such as multiple myeloma and monoclona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c89800ea9d060c2b2cc892917873d33
https://doi.org/10.1182/blood.v110.11.2477.2477
https://doi.org/10.1182/blood.v110.11.2477.2477
Autor:
Robert A. Kyle, Roshini S. Abraham, Raynell J. Clark, Ivana M. Micallef, Steve R. Russell, Morie A. Gertz, Angela Dispenzieri, Suzanne R. Hayman, Shaji Kumar, Philip R. Greipp, David J. Inwards, Michelle A. Elliott, Martha Q. Lacy, S. M. Ansell, Mark R. Litzow, S. Vincent Rajkumar, Patrick B. Johnston, Thomas E. Witzig, John A. Lust, Steve R. Zeldenrust, Jerry A. Katzmann, Luis F. Porrata
Publikováno v:
Blood. 106:422-422
Introduction: The immunoglobulin free light chain (FLC) is the precursor protein of amyloid in primary systemic amyloidosis (AL). Historically, the ability to monitor the amyloid protein precursor has been crude. There is now a test that reproducibly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::141163dee409bc26050de27b12294bc1
https://doi.org/10.1182/blood.v106.11.422.422
https://doi.org/10.1182/blood.v106.11.422.422